SCHEMBL6664649

SCHEMBL6664649

NC(=O)C=CSc1ccncc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
MAPT P10636 4/20 0.42
LMNA P02545 3/20 0.42
NPSR1 Q6W5P4 3/20 0.42
HTT P42858 2/20 0.42
PLIN1 O60240 1/20 0.42
HPGD P15428 1/20 0.42
PLIN5 Q00G26 1/20 0.42
ABHD5 Q8WTS1 1/20 0.42
CCNC P24863 3/20 0.41
CDK8 P49336 3/20 0.41
NFKB1 P19838 2/20 0.38
JUN P05412 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
DDAH1 O94760 1/20 0.38
NOS1 P29475 1/20 0.38
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
KDM4E B2RXH2 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6664645 1.00 ALDH1A1 (0.42) ALDH1A1MAPTLMNANPSR1HTT
SCHEMBL6943899 0.82 ALDH1A1 (0.47) ALDH1A1MAPTLMNANPSR1HTT
SCHEMBL6943902 0.82 ALDH1A1 (0.47) ALDH1A1MAPTLMNANPSR1HTT
SCHEMBL7456040 0.77 ALDH1A1 (0.60) ALDH1A1MAPTLMNANPSR1HTT
SCHEMBL6666397 0.73 CA1 (0.47) ALDH1A1MAPTLMNANPSR1HPGD
SCHEMBL6670734 0.71 NPSR1 (0.35) ALDH1A1MAPTLMNANPSR1HTT
SCHEMBL7455884 0.70 EHMT2 (0.45) ALDH1A1MAPTLMNAHPGDMEN1
SCHEMBL2817703 0.69 JUN (0.69) ALDH1A1MAPTLMNAHPGDCCNC
SCHEMBL2817704 0.69 JUN (0.69) ALDH1A1MAPTLMNAHPGDCCNC
SCHEMBL5717702 0.69 JUN (0.69) ALDH1A1MAPTLMNAHPGDCCNC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453828-A2 AZABICYCLIC COMPOUNDS FOR THE TREATMENT OF FIBROMYALGIA SYNDROME AstraZeneca AB (SE) 2004-09-08 EP claimed
WO-2003032897-A2 AZABICYCLIC COMPOUNDS FOR THE TREATMENT OF FIBROMYALGIA SYNDROME ASTRAZENECA AB (SE) 2003-04-24 WO claimed
EP-1235826-A1 QUINUCLIDINE ACRYLAMIDES AstraZeneca AB (SE) 2002-09-04 EP claimed
WO-2001029034-A1 QUINUCLIDINE ACRYLAMIDES ASTRAZENECA AB (SE) 2001-04-26 WO claimed